Logo

American Heart Association

  42
  0


Final ID:

The Expanding Therapeutic Options for Diabetic Kidney Disease: A Clinical Trial Overview

  • Neuen, Brendon  ( George Institute for Global Health , Newtown , New South Wales , Australia )
  • Agarwal, Rajiv  ( INDIANA UNIVERSITY SCHOOL MEDICINE , Indianapolis , Indiana , United States )
  • Rangaswami, Janani  ( Washington DC VA Medical Center , Falls Church , Virginia , United States )
  • Author Disclosures:
    Brendon Neuen: DO have relevant financial relationships ; Consultant:AstraZeneca:Active (exists now) ; Other (please indicate in the box next to the company name):Menarini - publication support:Active (exists now) ; Consultant:Travere:Active (exists now) ; Consultant:Otsuka:Active (exists now) ; Consultant:Novo Nordisk:Active (exists now) ; Other (please indicate in the box next to the company name):CSL Behring - travel support:Active (exists now) ; Consultant:CSL Seqirus:Active (exists now) ; Consultant:Boehringer and Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Alexion:Active (exists now) | Rajiv Agarwal: No Answer | Janani Rangaswami: DO have relevant financial relationships ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Procyrion:Active (exists now) ; Consultant:Bayer:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Diabetes, CKD and CVD Risk: From Mechanisms to Management

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts from these authors:
Cardiovascular Risk Prediction with the Kidney Failure Risk Equation Among Patients with Chronic Kidney Disease: Insights from CRIC

Correa Simon, Beldhuis Iris, Neuen Brendon, Vaduganathan Muthiah, Wilson F. Perry, Mc Causland Finnian

Incretin Analogues for Addressing Multisystem Morbidity

Neuen Brendon, Ndumele Chiadi

You have to be authorized to contact abstract author. Please, Login
Not Available